| Independent Reports (Showing 1 to 10 of 14) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 23-Nov-09 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 | $299 | View Abstract |
| 23-Nov-09 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 | $199 | View Abstract |
| 20-Nov-09 | Ford Investor Services, Inc. | N/A | Value Graph: HOLLIS-EDEN PHAR -- HEPH | 1 | $4 | View Abstract |
| 20-Nov-09 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ARYX , DSCO , HEPH , ICGN , MSHL , OGXI , PIP , SOMX -- DRUGS | 3 | $4 | View Abstract |
| 11-Nov-09 | Datamonitor | Datamonitor PLC | Hollis-Eden Pharmaceuticals, Inc. - Company Profile | 16 | $50 | View Abstract |
| 6-Nov-09 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Hollis-Eden Pharmaceuticals, Inc. | 42 | $65 | View Abstract |
| 4-Nov-09 | Global Markets Direct | Global Markets Direct | Hollis-Eden Pharmaceuticals, Inc. Financial and Strategic Analysis Review | 18 | $300 | View Abstract |
| 27-Oct-09 | EconomicInvestor | N/A | "The Economy Matters" Report for HEPH: the economy's impact on HEPH's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 | $15 | View Abstract |
| 30-Mar-09 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for BIOTECHNOLOGY | 18 | $49 | View Abstract |
| 30-Mar-09 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for HEPH | 13 | $25 | View Abstract |